Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

INDONESIA: Indonesia in Bold Move to Obtain Cheap Drugs for HIV


The Guardian (London) (10.11.12)

On September 3, Indonesia’s government quietly issued an order to override patents on seven important medicines used to treat individuals with HIV and hepatitis B, which will allow more inexpensive versions to be manufactured by local pharmaceutical companies. There appeared to be no protest from the pharmaceutical giants, who in the past would have defended their patents very aggressively. The drug patents belong to Merck, GSK, Bristol-Myers Squibb, Abbott, and Gilead. The drugs include Glaxo ’s Abacavir, Abbott’s Kaletra, and Gilead’s tenofovir (Viread) which treats hepatitis B as well as providing the primary prevention treatment for those whose partners are HIV positive. Indonesia’s HIV incidence rate is not particularly high—UNICEF estimates that nearly 310,000 individuals are infected—but it does have the fourth highest population in the world and the virus continues to spread. Only approximately 23,000 of the 70,000 individuals infected with HIV who need drug treatment are getting it.


Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in October 16, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.